PMID: 10924887Aug 5, 2000Paper

Methadone: a review of its pharmacokinetic/pharmacodynamic properties

Journal of Pharmacological and Toxicological Methods
M J Garrido, Iñaki F Trocóniz

Abstract

During the past decades the use of methadone has been increased as a result of the interest of optimizing its therapeutics in opioid addicts, one of the groups with higher risk for AIDS infection. However standard dose of methadone are far from being the appropriate for relief pain or prevent withdrawal signs in maintenance programs in many patients. To achieve an optimal dose regimen for an individual, the knowledge of the relationship between the pharmacokinetics/pharmacodynamics (pk/pd) drug properties and the demographic and physiopathological characteristics of the subject is required. Unfortunately, there is a lack of studies dealing with the population pk/pd properties of methadone. In the current study, a review of the pk/pd properties of methadone is presented with the aim of understanding the sources of variability in response. This will help in the design of prospective pk/pd studies; in particular, individual data including sex, weight, alpha(1)-acid glycoprotein levels in plasma, concomitant medications, time after starting treatment with methadone and previous exposure to other opioids should be requested. In addition, designs for drug administration should allow the characterization of the plasma-versus-biophase ...Continue Reading

References

Mar 1, 1975·Clinical Pharmacology and Therapeutics·E AnggårdH R Sullivan
May 1, 1990·Clinical Pharmacology and Therapeutics·C E InturrisiK M Foley
Apr 1, 1986·European Journal of Drug Metabolism and Pharmacokinetics·F P Abramson, M P Lutz
Apr 1, 1987·Clinical Pharmacology and Therapeutics·C E InturrisiK M Foley
Aug 1, 1985·Journal of Pharmacokinetics and Biopharmaceutics·J L GabrielssonL K Paalzow
May 1, 1973·Clinical Pharmacology and Therapeutics·G D Olsen
Jan 1, 1982·European Journal of Clinical Pharmacology·M I NilssonE Anggård
Feb 1, 1981·Clinical Pharmacology and Therapeutics·M K RomachE M Sellers
Jan 1, 1994·Chirality·N SchmidtG Geisslinger
Jan 1, 1993·European Journal of Clinical Pharmacology·K WolffR Calvert
Dec 1, 1995·Journal of Pharmacokinetics and Biopharmaceutics·D M Ouellet, G M Pollack
Mar 1, 1996·The Journal of Pharmacy and Pharmacology·M J GarridoR Calvo
Jun 1, 1996·Therapeutic Drug Monitoring·K KristensenP Sjøgren
Nov 1, 1996·Journal of Pharmacological and Toxicological Methods·T L PierceC Raper
Jan 10, 1997·The Journal of Biological Chemistry·A D BlakeT Reisine
Feb 1, 1997·Therapeutic Drug Monitoring·J N WilkinsW Ling
Jan 29, 1997·European Journal of Pharmacology·K W ChanB C Yoburn
May 8, 1999·British Journal of Clinical Pharmacology·D J FosterF Bochner
Jun 26, 1999·British Journal of Clinical Pharmacology·A Rostami-HodjeganG T Tucker
Feb 10, 2000·International Journal of Clinical Pharmacology and Therapeutics·M J GarridoR Calvo
Aug 23, 1965·JAMA : the Journal of the American Medical Association·V P DOLE, M NYSWANDER

❮ Previous
Next ❯

Citations

Apr 22, 2008·Molecular Diagnosis & Therapy·Yongfang LiSiamak Davani
Mar 17, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·C M NegrínC Evora
Feb 14, 2002·Drug and Alcohol Dependence·Magí FarréJordi Camí
May 22, 2003·Drug and Alcohol Dependence·Robert S MansbachSidney H Schnoll
Apr 12, 2011·Child Neuropsychology : a Journal on Normal and Abnormal Development in Childhood and Adolescence·Carolien Konijnenberg, Annika Melinder
Apr 13, 2012·Therapeutic Drug Monitoring·Sarah K HimesMarilyn A Huestis
Jun 11, 2004·Annual Review of Biochemistry·Maria WaldhoerJennifer L Whistler
Jan 17, 2007·Critical Care : the Official Journal of the Critical Care Forum·Bruno MégarbaneFrédéric J Baud
Jan 31, 2008·Current Oncology·J Myers, N Shetty
Sep 14, 2014·Journal of Analytical Toxicology·Lauren L Richards-WaughGary O Rankin
May 23, 2001·Journal of Pain and Symptom Management·R AndersonC Schlicht
Jun 21, 2008·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Douglas J Weschules, Kevin T Bain
Apr 22, 2015·Acta neurologica Belgica·Grace Y WangBruce R Russell
Sep 17, 2003·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Douglas J WeschulesCalvin H Knowlton
Apr 4, 2008·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Douglas J WeschulesSteven Richeimer
Mar 12, 2008·Acta Anaesthesiologica Scandinavica·O M S FredheimO Dale
May 20, 2011·Substance Abuse Treatment, Prevention, and Policy·Kenneth M Dürsteler-MacFarlandSylvie A Petitjean
Mar 3, 2007·Annals of the New York Academy of Sciences·Edward J Cone, Marilyn A Huestis
Oct 31, 2014·Child Neuropsychology : a Journal on Normal and Abnormal Development in Childhood and Adolescence·Carolien Konijnenberg, Annika Melinder
Jun 12, 2009·Drug Metabolism Reviews·Shu-Feng ZhouBalram Chowbay
May 8, 2013·Journal of Pain & Palliative Care Pharmacotherapy·Natalie M Latuga, Robert G Wahler
Jun 25, 2015·Frontiers in Pharmacology·Manuela Graziani, Robert Nisticò
Oct 11, 2014·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Grace Y WangBruce R Russell
Oct 27, 2004·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Anna FerrariEmilio Sternieri
Dec 11, 2007·Current Opinion in Neurobiology·Lene Martini, Jennifer L Whistler
Apr 22, 2004·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Scott M FishmanPatricia Molina
Jul 28, 2016·International Journal of Legal Medicine·Xiulu RuanAlan David Kaye
Aug 2, 2015·Biochemical Pharmacology·Reeta TalkaOuti Salminen
Jul 7, 2018·Developmental Neuropsychology·Carolien KonijnenbergAnnika Melinder
Nov 23, 2006·European Journal of Pain : EJP·Olav Magnus S FredheimOla Dale
Feb 23, 2010·Journal of Clinical Pharmacology·Matt S AndersonMarian Iwamoto
Mar 24, 2007·Pharmaceutical Research·Ignacio OrtegaRosario Calvo
Jan 27, 2007·Current Oncology Reports·John BrysonCamilla Zimmermann
Jan 8, 2009·Current Pain and Headache Reports·Jodie A Trafton, Abhinav Ramani
Dec 7, 2007·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Viktoria Kharlamb, Helen Kourlas
May 6, 2005·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Philip W H PengDouglas Gourlay
Nov 12, 2009·Clinical Pharmacokinetics·Shu-Feng Zhou
Nov 15, 2005·Journal of Pharmacokinetics and Pharmacodynamics·David J R FosterAllison Martinez
Sep 18, 2012·Paediatric Anaesthesia·Christopher J StemlandBrian J Anderson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.